Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
79.17
-0.41 (-0.52%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Stock Picks 2024: 7 Trailblazers Using AI to Revolutionize Their Industries
January 03, 2024
Although AI-related stock picks for 2024 may be centered on tech firms, the innovation itself achieves broad relevance.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
January 03, 2024
Via
Benzinga
Boston Scientific Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
December 29, 2023
Via
Benzinga
Why Medical Devices Behemoth Boston Scientific Shares Are Rising Friday
December 29, 2023
Boston Scientific Corporation (NYSE: BSX) said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get
Via
Benzinga
NYSE:BSX may be ready to breakout.
December 28, 2023
BOSTON SCIENTIFIC CORP (NYSE:BSX) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Via
Chartmill
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
December 21, 2023
Via
Benzinga
(BSX) - Analyzing Boston Scientific's Short Interest
December 19, 2023
Via
Benzinga
Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return
December 22, 2023
Via
Benzinga
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
December 15, 2023
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising
Via
Benzinga
Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest Holdings
December 14, 2023
These two stocks and one ETF helped the billionaire's hedge fund make a boatload of money in 2023.
Via
The Motley Fool
Topics
ETFs
What 18 Analyst Ratings Have To Say About Boston Scientific
December 13, 2023
Via
Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
December 13, 2023
Via
Investor Brand Network
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
December 11, 2023
Via
Benzinga
Uncovering Noteworthy Technical Analysis Findings for BOSTON SCIENTIFIC CORP (NYSE:BSX).
December 04, 2023
In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP.
Via
Chartmill
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
December 01, 2023
Via
Investor Brand Network
Peering Into Boston Scientific's Recent Short Interest
November 29, 2023
Via
Benzinga
3 Healthcare Stocks to Pick Up Before the Year-End Rally
November 28, 2023
Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending
Via
InvestorPlace
Will Boston Scientific Corporation (BSX) Continue Further upside?
November 28, 2023
Boston Scientific Corporation (BSX) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular...
Via
Talk Markets
Expert Ratings for Boston Scientific
November 27, 2023
Via
Benzinga
Could Ozempic Harm These 3 Medical Device Stocks?
November 25, 2023
The drug is on track to cause massive competitive shifts in the healthcare sector.
Via
The Motley Fool
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
November 22, 2023
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.
Via
InvestorPlace
A Look Into Boston Scientific Inc's Price Over Earnings
November 22, 2023
Via
Benzinga
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
November 16, 2023
Via
Benzinga
Looking Into Boston Scientific's Recent Short Interest
November 10, 2023
Via
Benzinga
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
November 03, 2023
Via
Benzinga
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming
November 15, 2023
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock.
Via
Investor's Business Daily
Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
November 13, 2023
Via
AB Newswire
Exposures
Product Safety
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Medical Devices Provider Boston Scientific Cardiovascular Segment Sees Traction In Q3, Company Adjusts Annual Outlook
October 26, 2023
Boston Scientific Corp (NYSE: BSX) generated Q3 revenues of $3.53 billion, beating the Wall Street estimate of $3.48 billion.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.